BioCentury
ARTICLE | Financial News

Genzyme up further on takeout rumors

July 27, 2010 12:49 AM UTC

Shares of Genzyme Corp. (NASDAQ:GENZ) gained $4.86 to $67.38 on Monday, putting it up 24% since reports surfaced on Friday that sanofi-aventis Group (Euronext:SAN; NYSE:SNY) had approached the biotech...